Navigation Links
New developments in biomarkers for epithelial ovarian cancer
Date:11/29/2007

AMSTERDAM, November 29th 2007 With the genomic revolution radical improvement has been made in methods of detection of ovarian cancer. This is of the utmost importance, since the chances of successful treatment are strongly enhanced with early detection. In a special issue of Disease Markers, published by IOS Press, eleven articles explore new developments in the identification and understanding of biomarkers for epithelial ovarian cancer.

Many of these biomarkers may serve not only as markers of clinical and biology interest but also as potential therapeutic and imaging targets which could significantly improve the survival of patients with this disease, states Prof. Michael J. Birrer (National Cancer Institute, Center for Cancer Research, Cell and Cancer Biology Department, MD, USA).

Discussed in the issue are new hypotheses on the molecular development of ovarian cancer, SP markers of risk, biomarkers that are specific for the different histological subtypes, and new biomarkers and approaches for the early detection of ovarian cancer. Furthermore, new molecular technologies have allowed for the analysis and characterization of specific cellular components of ovarian tumors identifying biomarkers of tumor associated immune and endothelial cells.


'/>"/>

Contact: Wilbert van der Sluijs
w.van.der.sluijs@iospress.nl
31-206-883-355
IOS Press
Source:Eurekalert

Page: 1

Related medicine news :

1. DTI Medical Corporation Announces Reverse Split and Other Corporate Developments
2. PainCare Reports on Key Corporate Developments
3. New Report Provides Insight Into Developments in the Market for Anxiety and Depression Therapies
4. Cejka Search Experts Present Latest Developments in Physician and Healthcare Employment at Leading Industry Conferences
5. MGT Capital Investments Reports Third Quarter 2007 Financial Results and Provides Update on Recent Developments
6. Penn School of Medicine receives $2.3 million to study biomarkers of cigarette smoke exposure
7. Study makes progress in zoning in on biomarkers for better colon cancer treatment
8. Biomarkers predict risk for invasive breast cancer years before the tumor develops
9. JDRF and Lilly partner to fund research to identify beta cell biomarkers
10. Biomarkers for Alzheimers disease can be trusted in clinical trials
11. Cranberry Could Juice Up Ovarian Cancer Treatment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/26/2017)... Barcelona, Spain (PRWEB) , ... September 26, 2017 ... ... exciting nutritional ingredient that is not only entirely new and different, it is ... extracts, announced today that the company has received an exclusive license agreement with ...
(Date:9/26/2017)... ... September 26, 2017 , ... Data Integrity: , The ... **, Dec. 5-6, 2017 – Arlington, VA, http://www.fdanews.com/fdadataintegrity , ... indicate the firm’s electronic records may not be trustworthy and reliable … a more ...
(Date:9/26/2017)... ... September 26, 2017 , ... The 2017 American Academy ... “The Magic of Fat,” revealed not only the latest about cosmetic procedures to remove ... an evolution in cosmetic medicine. , “Fat really is magical, especially when it comes ...
(Date:9/26/2017)... ... ... “Good Morning Sunshine!: Finding Strength and Comfort in God”: a hopeful and ... Comfort in God” is the creation of published author, Terri Braun, a mother of ... at a local mental health center for over twenty years, helping the severely and ...
(Date:9/26/2017)... ... September 26, 2017 , ... “Sonflower Submission”: a relatable and concise reality ... destinations of negativity, complaining and the need to always be correct. There comes a ... for a lesson in stress-less living to be learned. “Sonflower Submission” is the ...
Breaking Medicine News(10 mins):
(Date:9/25/2017)... PROVIDENCE, R.I. , Sept. 25, 2017 /PRNewswire/ ... immunogenicity assessment, vaccine design, and immune-engineering today announced ... focused on the development of personalized therapeutic cancer ... and has provided exclusive access to enabling technologies ... MSc Eng., MBA will lead EpiVax Oncology as ...
(Date:9/22/2017)... Md. , Sept. 22, 2017  As the ... Republican Senators Bill Cassidy (R-LA) and ... Information notes that the medical device industry is in ... medical device tax, the 2.3% excise tax on medical ... But they also want covered patients, increased visits and ...
(Date:9/19/2017)... Inc., a venture-backed medical device company developing a non-invasive, robotically assisted, platform therapy that uses ... today:   ... Jim ... Tom Tefft ... Veteran medical device executive Josh Stopek , PhD, who has led R&D and business ...
Breaking Medicine Technology: